| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2021 | DHR Danaher Corp /de/ | Rales Mitchell P70 | Chairman Of Exec. Committee | Buy | 6,600 | $221.55 | $1,462,260.00 | +0.3% | +16.3% | +27.5% | |
| Feb 25, 2021 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 8,735 | $281.70 | $2,460,614.99 | -13.6% | - | - | |
| Feb 25, 2021 | EXAS Exact Sciences Corp | Coward D Scott77 | Chief Administrative Officer | Sell | 6,788 | $132.96 | $902,532.48 | -83.9% | - | - | |
| Feb 25, 2021 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $154.00 | $82,852.00 | -10.4% | - | - | |
| Feb 25, 2021 | VCYT Veracyte, Inc. | Eastham Karin65 | Director | Sell | 6,250 | $60.70 | $379,358.58 | -60.9% | - | - | |
| Feb 25, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 28,750 | $79.96 | $2,298,881.78 | -0.2% | - | - | |
| Feb 25, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Co-founder | Sell | 1,038 | $106.69 | $110,746.09 | -0.2% | - | - | |
| Feb 25, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,899 | $106.73 | $202,682.78 | -1.7% | - | - | |
| Feb 24, 2021 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 24,009 | $284.75 | $6,836,606.97 | -0.9% | - | - | |
| Feb 24, 2021 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Buy | 5,000 | $14.42 | $72,100.00 | New | - | - | |
| Feb 24, 2021 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 5,842 | $136.30 | $796,264.60 | -12.4% | - | - | |
| Feb 24, 2021 | EXAS Exact Sciences Corp | Condella Sarah75 | SVP, Human Resources | Sell | 2,057 | $136.30 | $280,369.10 | -2.8% | - | - | |
| Feb 24, 2021 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 15,000 | $81.57 | $1,223,481.29 | -0.3% | - | - | |
| Feb 24, 2021 | EXAS Exact Sciences Corp | Coward D Scott77 | Chief Administrative Officer | Sell | 24,812 | $136.46 | $3,385,813.10 | -52.7% | - | - | |
| Feb 24, 2021 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 16,420 | $136.30 | $2,238,046.00 | -2.0% | - | - | |
| Feb 24, 2021 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 4,449 | $136.30 | $606,398.70 | -9.0% | - | - | |
| Feb 23, 2021 | NOTV Inotiv, Inc. | Beattie John Gregory | Chief Operating Officer | Buy | 8,288 | $14.00 | $116,032.00 | +55.3% | - | - | |
| Feb 23, 2021 | CRL Charles River Laboratories International, Inc. | Chubb Stephen D | Director | Sell | 658 | $281.66 | $185,330.37 | -1.6% | - | - | |
| Feb 23, 2021 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 37,731 | $281.27 | $10,612,695.56 | -1.1% | - | - | |
| Feb 23, 2021 | TTOO T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Sell | 7,280 | $2.06 | $14,996.80 | -10.0% | - | - | |
| Feb 23, 2021 | TTOO T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Sell | 5,250 | $2.04 | $10,710.00 | -12.9% | - | - | |
| Feb 23, 2021 | TTOO T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Sell | 7,280 | $2.06 | $14,996.80 | -10.0% | - | - | |
| Feb 22, 2021 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 5,000 | $124.17 | $620,850.00 | -10.8% | - | - | |
| Feb 19, 2021 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 500,000 | $4.77 | $2,383,454.76 | - | - | - | |
| Feb 19, 2021 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 8,656 | $290.63 | $2,515,685.71 | -70.1% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.